# Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study\.

> A sourced UK public-sector contract award published by UNIVERSITY OF NOTTINGHAM \(THE\).

## Key facts

- Public buyer: [UNIVERSITY OF NOTTINGHAM \(THE\)](/buyers/university-of-nottingham-the/contract-awards)
- Contract winner: MEDICINES DISCOVERY CATAPULT SERVICES LIMITED
- Award value: £76,536
- Tender value: £76,536
- Award date: 5 May 2022
- Published: 27 January 2023
- Contract start: 5 May 2022
- Contract end: 5 May 2022
- Stage: awarded
- Procurement category: services
- Notice ID: b7fe11c2-b9bc-4f06-8d38-f5d56d677deb-609355
- OCID: ocds-b5fd17-74cf7efb-12b0-4713-adbc-9ac8b71113ed

## Description

The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform\.

## Related contract awards

- [Graduation Services](/contracts/ocds-b5fd17-e1b1b2d7-5a85-44b5-8573-65ea604fa7db): UNIVERSITY OF NOTTINGHAM \(THE\)
- [Institute for Technical Skills & Strategy \(ITSS\) Specialist Consultancy](/contracts/ocds-b5fd17-c77c0703-3493-4016-8d68-71378a723360): UNIVERSITY OF NOTTINGHAM \(THE\)
- [2273 ITTO EW - Provision of PRINCE2 Training Package](/contracts/ocds-b5fd17-ce2f9667-60ad-4f19-ae2a-9c4926ebd13c): UNIVERSITY OF NOTTINGHAM \(THE\)
- [MDCS - Winter Capacity \(21/22\)](/contracts/ocds-b5fd17-61aa0803-a980-4351-bbeb-4a13df52a213): UK Health Security Agency
- [Winter Surge Capacity \(21/22\)](/contracts/ocds-b5fd17-4dacf52e-3468-4341-89ba-7de1eb0c1c2e): ATAMIS LTD

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/b7fe11c2-b9bc-4f06-8d38-f5d56d677deb-609355)